dc.creatorMucci, Juan Marcos
dc.creatorRozenfeld, Paula
dc.date2015
dc.date2019-11-21T16:18:08Z
dc.date.accessioned2023-07-14T17:33:01Z
dc.date.available2023-07-14T17:33:01Z
dc.identifierhttp://sedici.unlp.edu.ar/handle/10915/85889
dc.identifierissn:2314-8861
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/7427912
dc.descriptionGaucher, the most prevalent lysosomal disorder, is an autosomal recessive inherited disorder due to a deficiency of glucocerebrosidase. Glucocerebrosidase deficiency leads to the accumulation of glucosylceramide primarily in cells of mononuclear-macrophage lineage. Clinical alterations are visceral, hematological, and skeletal. Bone disorder in Gaucher disease produces defects on bone metabolism and structure and patients suffer from bone pain and crisis. Skeletal problems include osteopenia, osteoporosis, osteolytic lesions, and osteonecrosis. On the other hand a chronic stimulation of the immune system is a well-accepted hallmark in this disease. In this review we summarize the latest findings in the mechanisms leading to the bone pathology in Gaucher disease in relationship with the proinflammatory state.
dc.descriptionInstituto de Estudios Inmunológicos y Fisiopatológicos
dc.formatapplication/pdf
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by/3.0/
dc.rightsCreative Commons Attribution 3.0 Unported (CC BY 3.0)
dc.subjectBiología
dc.subjectGaucher Disease
dc.subjectGlucosylceramidase
dc.subjectEnzyme glucocerebrosidase
dc.titlePathogenesis of Bone Alterations in Gaucher Disease: The Role of Immune System
dc.typeArticulo
dc.typeRevision


Este ítem pertenece a la siguiente institución